The discovery that collateral development after progressive coronary stenosis proceeds by means of DNA synthesis, mitosis and proliferation of endothelial and smooth muscle cells in preformed small interconnecting arterioles (canine heart) and capillaries (porcine heart) has stimulated research into the molecular mechanisms of vascular growth. Growth is tightly controlled under physiologic conditions, and several factors must act in concert to overcome control. Because the result of growth is a much larger orderly structure of complex design, we expect the existence of a genetic blueprint for its construction.
Molecular Biologic Concepts of Coronary Anastomoses
The discovery that collateral development after progressive coronary stenosis proceeds by means of DNA synthesis, mitosis and proliferation of endothelial and smooth muscle cells in preformed small interconnecting arterioles (canine heart) and capillaries (porcine heart) has stimulated research into the molecular mechanisms of vascular growth. Growth is tightly controlled under physiologic conditions, and several factors must act in concert to overcome control. Because the result of growth is a much larger orderly structure of complex design, we expect the existence of a genetic blueprint for its construction. Peptide growth factors have recently been isolated from a variety of organs, including the heart. We have provided experimental evidence that the heparin-binding growth fac-
The most interesting aspect of coronary anastomoses is their ability to respond with growth when the large epicardial arteries become stenosed and occluded and the tissue becomes potentially ischemic. This growth adaptation can be very efficient, and cases have been described in which chronic occlusion of the left main coronary artery was tolerated without infarction. Several reports (1,2) have shown that regional left ventricular wall function was preserved in the presence of proximal left anterior descending coronary artery occlusion. Collateral flow adaptation is not always that efficient, and acute myocardial infarction is not only a consequence of coronary occlusion, it is also a consequence of failure of the collateral circulation.
Several reasons for failure of collateral vessels to prevent infarction are known. The most important is probably the time factor: if a coronary artery that is only minimally stenosed becomes acutely occluded, the growth adaptation tor beta-ECGF shows an increased transcription in growing pig collateral vessels. Because the chain of events probably originates in the ischemic cardiac myocyte, it appears logical to search there for the initiating factor. In addition to local production, growth factors can also be transported into ischemic myocardium by blood-borne cells. Monocytes adhere to altered endothelium in a potentially ischemic region and start to produce growth factors in situ. Platelets are rich sources of transforming growth factor-beta (TGF-/I), platelet-derived endothelial cell growth factor (PDECGF) and platelet-derived growth factor (PDGF), all of which are known angiogenic factors or mitogens.
(J Am Co11 Cardiol1990; 15:513-8) of collateral vessels cannot occur because they require approximately 24 h of response and about 3 days to completion. If acute thrombosis of coronary arteries can be prevented in the future by medication and changes in life-style, the collateral circulation is certainly able to prevent infarction in many more patients than previously thought possible. If we understood the process of coronary angiogenesis better, we might be able to support it in the future with new medicines.
Laboratory Models of Collateral Vessel Growth
Long-term coronary artery occlusion by ameroid constrictor. We studied (3) slowly progressing coronary artery occlusion in dogs and pigs after long-term implantation of ameroid rings. These rings consisted of a hygroscopic plastic material (originally casein hardened with formalin) that swells and compresses the artery. The rings were originally encased by a band of stainless steel to prevent outward swelling, but we recently simplified this procedure by using a strong ligature instead of the steel ring because it does not produce a shadow for in vivo coronary angiography. Depending on its (somewhat controllable) ability to absorb water, the ameroid occluded the artery at approximately 17 days (range 12 to 21). However, swelling of the constrictor by water uptake does not fully explain coronary artery occlusion. The formation of platelet thrombi within the stenosed and poststenotic segments contributes to the completion of the stenosis and may cause sudden death. The foreign body reaction around the constrictor and its subsequent shrinkage may also contribute to complete occlusion. Sixty-six percent of dogs with occlusion of the left circumflex artery plus the right coronary artery by this method survived. Death in the other 33% was caused by acute ventricular fibrillation.
whether repeated brief occlusions are the most efficient method for eliciting these factors because it can be argued that most of what was produced during ischemia may get lost during the subsequent periods of reactive hyperemia and normoxia. The procedure may also cause various adaptations other than collateral vessel growth (for example, "stunning," "preconditioning" or enzyme induction) as well as changes in the concentration, synthesis and breakdown of adenosine triphosphate (ATP), glycogen, lipids and the like.
The predominant left coronary artery branch in the pig is the left anterior descending artery, followed in importance by the right coronary artery. A proximal occlusion of the left anterior descending or right coronary artery in the pig by ameroid constrictor is poorly tolerated. Although mortality is not excessively higher than in the dog, a large infarct develops and complicates the interpretation of collateral vessel development because the vascular growth processes of wound healing may differ from those of collateral vessel growth. The response of the pig heart is markedly influenced by the almost complete lack of collateral vessels in contrast to the dog, in which collateral blood flow can be 30% of the normal blood flow at rest. Therefore, in our experiments in pigs, we occluded the left circumflex coronary artery, which is the smallest of the three epicardial arteries in the pig, and placed the constrictors downstream from the first marginal branch. This procedure resulted in a 30% mortality rate from ventricular fibrillation, and about 50% of the survivors were free of macroscopic infarcts.
The most important advantage of this method is its ability to produce collateralJiow without infarction. Repeated 2 min periods of ischemia do not cause necrosis. Tissue necrosis (often as focal mini-infarcts) is a complicating factor in ameroid occlusion because angiogenesis after wound healing may differ from the process of collateral vessel growth. Our experience with this method in pigs (5) was not particularly encouraging. Although we followed the Franklin protocol of a 2 min occlusion every 30 min, 8 h/day, 5 days/week for 4 weeks and for up to 400 occlusions, many animals died because of reperfusion ventricular fibrillation. The long-term implants and the irritation they caused led to adhesions that by themselves produced ingrowth of vessels that served as collateral vessels. The same result was achieved after 4 weeks whether or not the cuff was occluded, PS just described.
Vascular Growth as the Underlying Principle of Collateral Flow Adaptation
Often-repeated brief occlusions. Utilizing a method developed in Dean Franklin's laboratory, Yamamoto et al. (4) employed brief coronary occlusions (2 min, once every 30 min) produced with a chronically implanted inflatable cuff. After about 100 occlusions in the dog, an occlusion did not produce changes in regional contractility, and it was not followed by a reactive hyperemia response. A plausible explanation would be to assume that the collateral vessels had formed. On the basis of radioactive tracer microspheres and postmortem angiograms, this was later shown to be the case. An important conclusion from this experiment was that a relation exists between the number of collateral vessels already present before the start of repetitive occlusions and the number of occlusions necessary to produce collateral flow. More occlusions were needed in animals with no or only a few original collateral vessels. Dogs with few original collateral vessels needed more occlusions than did dogs with many original collateral vessels.
When dogs at the critical stage of ameroid-induced coronary stenosis receive the metaphase poison colchicine, numerous mitoses of endothelial and smooth muscle cells can be observed in excised and visibly enlarged collateral vessels (but not in normal coronary arteries of the same size). When animals receive tritiated thymidine during collateral vessel development, numerous nuclei contain radioactive deoxyribonucleic acid (DNA) that can be detected by autoradiography (3). Experiments with a remote-controlled mercuryfilled coronary constrictor cuff have shown (6) that, if the time from onset of coronary narrowing to complete occlusion is 3 days, endothelial cells have the most frequently labeled nuclei, followed by adventitial fibroblasts and smooth muscle cells. If the time from onset of narrowing to occlusion is 6 days, the vascular smooth muscle is the most heavily labeled, followed by adventitial fibroblasts and endothelium. From these experiments, we concluded that the endothelium leads the process of growth adaptation and that smooth muscle follows. An endothelial-smooth muscle interaction process is very likely and should be studied.
Another important conclusion was that the ischemic
In ameroid occlusion, thymidine-labeled vascular cells are stimulus had to be of a certain intensity to cause an effect. A most frequent at approximately 3 weeks after implantation of 15 s occlusion every 2.5 min was ineffective, although the the constrictor, which corresponds to about 3 days after amount of occlusion time per hour was the same. It is complete occlusion, and labeling decreases sharply thereafter assumed that the intensely ischemic myocardium produces (7). At 8 weeks after implantation (which is about 5 weeks certain factors responsible for collateral vessel growth. The after occlusion), the labeling index is low but still significantly nature of these factors is unknown. It is also unknown above that of control tissue from the same heart.
In porcine hetwrs, occlusion of the distal left circumflex coronary artery also leads to a marked increase of the thymidine-labeling index (8). In contrast to our findings in dogs, the index was increased in the entire heart. but significantly more so in the region at risk of &hernia. In the porcine heart, collateral vessel growth additionally differs in that all classes of vessels in the entire risk region participate in the growth process (that is, nuclei of all classes of vessels are labeled) and morphometric studies (9) show increases in the total luminal area of most classes of small vessels.
Comparison With the Human Heart
Based on systematic studies by Fulton (10) and coronary cineangiography. general agreement exists that in human coronary artery disease, a subendocardial plexus of collateral vessels develops and links the region at risk of infarction with its better perfused adjacent regions. The appearance of this plexus in postmortem tomoangiograms is that of an increased density of injected small vessels. The response of the porcine heart to progressive coronary occlusion appears very similar: a dense blush of injected microvessels appears throughout the thickness of the left ventricular wall and is somewhat more prominent subendocardially than near the subepicardium. This is probably the angiographic correlate of the generalized vascular growth response to ischemia in the porcine heart ( I I). In the human heart, coronary angiography performed either in vivo or after death sometimes reveals larger anastomoses at or near the epicardium than in the endocardium. Large anastomoses often traverse the atria in the diseased human heart, thereby connecting proximal with distal segments of the same occluded coronary artery. or they connect branches of the right with those of the left coronary artery. In the porcine heart, larger collateral vessels are not detectable on the epicardial surface. but sometimes one or more macroscopically visible anastomoses traverse the posterior papillary muscle (12) .
From these ohsenw~ions
kt'e tan stq rhtrt neifhcr the porcine nor the canine coronary mtery system complt~tcly resen~hlrs the prrttern of t~ollcr~erali~ation of' the humtrn heart. The contribution of numerous small precapillary vessels, similar in pig and human but completely absent in the canine heart, makes the pig a somewhat more relevant model than the dog. However, the dog heart has served as a valuable model to work out the stages of growth adaptation in response to progressive occlusion. The dog model may also help explain the developments of large epicardial anastomoses in humans.
Role of Growth Factors Versus Physical Forces in Collateral Vessel Enlargement
In the 1960s and 197Os, the stimulus for vascular growth was believed to be of physical nature. Changes in pressure gradients with the progression of stenosis (13) . changes in SCHAPER ET AL.
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the flow velocity and viscous drag (14) acting on the endothelium and on the entire vessel wall and changes in tangential wall tension brought about by ischemic vasodilation (15) were all believed to act as triggers of growth. In 1972, we (3) postulated that the increased mechanical stress acting on the cell membrane must be transduced to the nucleus to respond with mitosis, but the detailed pathway was not apparent at that time. The change in our attitude toward primarily biochemical transmitters of growth occurred when we evaluated the thymidine-labeling index in tissue sections after graded steps of stenosis (6): a small but significantly increased label incorporation was also observed in veins near more heavily labeled arterioles. Because physical forces differ greatly between arteries and veins. a nonphysical force must have been active.
Growth Factors Can Be Carried Into Ischemic Tissue by Blood Cells
Growth factors (that is, mitogenic peptides) can be isolated from the heart (16), but uncertainties exist with regard to their physiologic and pathophysiologic role and to whether those that become active in the tissue after progressive coronary stenosis were produced on site. released from storage sites or carried into the tissue by growth factor-laden cells (platelets) or by growth factor-producing cells (monocytes-macrophages).
Role of platelet invasion. We (17.18) have observed the invasion of transforming vascular walls by monocytes and platelets. Platelets are a particulairy rich source of growth factors. The smooth muscle mitogen platelet-derived growth factor (19) . the endothelial mitogen platelet-derived endothelial cell growth factor (PDECGF) (20) and the nonmitogenic but angiogenic transforming growth pdctor (TGF-P) (21) have all been isolated from platelets. Although it may be expected that platelets and their growth factors play an important role in collateral vessel growth, the invasion of platelets into the wall of collateral vessels is only infrequently observed. Platelet invasion occurs mainly at vascular segments that appear markedly damaged and where other blood elements like extraluminal erythrocytes are also present.
Role of monocytes-macrophages. Because vascular growth also occurs in nondamaged vascular segments and because intraluminal platelet aggregates are uncommon in the collateral vessels themselves, we doubt a very prominent role of platelet-derived growth factors. However, a coronary stenosis upstream may cause a "showering" of aggregated platelets that are then lysed in the microvasculature, thus escaping detection but nevertheless aiding in growth of the microvasculature. Monocytes-macrophages adhering to and invading vascular wall segments of growing collateral vesse13 are very frequently observed in developing canine but not in porcine collateral vessels. The role of these cells that are producers of the angiogenic tumor necrosis factor (TNF-ol) is, therefore, not entirely clear. The problem may be one of detection: large canine collateral vessels were longitudinally slit and the intimal surface was viewed in the scanning electron microscope. What appears numerous in low power scanning electron microscopy is much more difficult to detect in thin transverse sections in the transmission electron microscope. Because no large collateral vessels are produced in the porcine heart, there is only a small chance of detecting macrophages in small vessels. We are not aware of the existence of macrophage-specific antibodies against porcine macrophages (antihuman macrophage antibodies do not cross-react). Availability of such antibodies would aid in the detection of macrophages in tissue because of the fluorescence labeling of the secondary antibody.
Growth Factors Can Be Isolated From Normal Myocardium
Fibroblast growth factor. The observation of vascular growth initiated by ischemia leads us to search for a mitogen. The idea of employing the "grind and find" approach on the protein level using only tissue with observable vascular growth was quite discouraging because of the large number of experimental animals needed. On the other hand, vascular mitogens had been discovered in the normal bovine brain at times when no vascular growth takes place. Beta-endothelial cell growth factor, its truncated form acidic fibroblast growth factor and its 35% homologue basic fibroblast growth factor were isolated from brain (22) using heparin affinity chromatography. We applied this method in slightly modified form to the normal heart, and were able to extract, purify and sequence acidic and basic fibroblast growth factor and its truncated form, angiogenetic fibroblast growth factor (16) . By proteolytic cleavage of the beta-endothelial cell growth factor, we showed species differences in molecular composition and minor amino acid sequence variations.
The mitogen receptor barrier in the extracellular matrix. The presence of strong mitogens in the normal heart with no detectable vascular growth would suggest that a barrier normally exists between the mitogen and its receptor. Such a barrier may be the extracellular matrix in which the heparin-binding growth factors are believed to be stored. This hypothesis remains uncertain because the gene structure of the fibroblast growth factors does not show a preproform (that is, a sequence coding for a signal peptide that enables the hormone to cross the cell membrane on its way out of the cell). With other tissue hormones that occupy receptors on the outer envelope of the cell membrane, these sequences are known and are cleaved off by specific proteases when the protein complex enters the domain of the plasma membrane. The absence of this signal sequence makes it difficult to understand how the fibroblast growth factors can get into the extracellular matrix. This problem is not unique to the fibroblast growth factors: two other growth factors also do not have signal peptides (that is, interleukin and platelet-derived endothelial cell growth factor). Therefore, some investigators (23, 24) believe that the fibroblast growth factors will leave the cell only after significant damage (as in ischemia). The free hormone can then occupy receptors of surviving cells in the region that will then respond with mitosis.
Localization of fibroblast growth factor. The microscopic localization of acidic fibroblast growth factor is difficult because of the low concentrations of this hormone in cells. After preincubation of cells with acidic fibroblast growth factor and with the use of residual light amplification, a localization near the nucleolus was found. Using monoclonal antibodies that we developed against acidic fibroblast growth factor, a similar localization was found in cultured endothelial cells but without preincubation. To date, we have not been able to show enhanced expression of the protein in the collateralized heart. However, this may be due to the fact that the amounts produced with enhanced expression are still too low for detection with immunohistochemistry.
Growth Factor Transcription Is Enhanced in Collateralized Myocardium
Transcription of growth factor genes. A more sensitive and specific way to study growth factor expression is to measure the transcription of the growth factor genes. This is done by extraction of messenger ribonucleic acid (RNA) from normal and collateralized myocardial regions, gel electrophoresis of the RNA and blotting of the RNA on filter membranes where it is "probed" with radioactively labeled cDNAs for known growth factors (Northern blot hybridization). Under physiologic conditions in normal hearts, messenger RNA for acidic fibroblast growth factor cannot be detected. With progressive coronary stenosis and induced collateralization, acidic fibroblast growth factor transcripts are detectable by Northern blot hybridization. We further investigated the transcription of the angiogentic peptide TGF-P and found enhanced transcription also in collateralized tissue. Another way to study transcription is to amplify known segments of transcripts after selective reverse transcription with the polymerase chain reaction. Because of the extreme sensitivity of this method, we found transcription of TGF-/3 in the control as well as in the collateralized region of the porcine heart. The polymerase chain reaction is difficult to calibrate, and we interpret the differences between the Northern blots and polymerase chain reaction as enhanced expression of TGF-/3 (in collateralized tissue detectable by Northern blot hybridization) that shows a basal level of transcription (detectable by polymerase chain reaction) in normal tissue.
Localization of growth factor transcription. Northern blot hybridization and polymerase chain reaction are able to show whether there is transcription and how much. However, these methods cannot show where transcription occurs. This can be studied by in situ hybridization where radioactive cDNA is hybridized to its complementary messenger RNA in a tissue section. In situ hybridization is a complex technique, and special problems exist with the cDNA for acidic fibroblast growth factor because it has GC-rich sequences that tend to form "hairpins" and consequently do not hybridize with messenger RNA. We collaborated with Kandolf (Max Planck Institute for Biochemistry), who was able to detect acidic fibroblast growth factor transcripts (but not basic fibroblast growth factor transcripts) only in vascular walls in collateralized porcine myocardium and not in normal myocardium.
Collateral Vessel Growth Is the Result of a Growth Factor Cascade
Resistance to ischemia of microvascular endothelium versus cardiac monocytes. The detection of acidic fibroblast growth factor transcripts over blood vessel walls in collateralized porcine hearts with a heterologous (human) cDNA probe came as a surprise because we had assumed that the ischemic cardiac myocytes would produce the mitogen. In heart tissue, mainly the cardiac myocytes will react to a shortage of oxygen as it occurs with progressive stenosis. Vascular tissue will probably never become ischemic in the canine heart, not even with acute coronary occlusion, because residual blood flow (arterial in nature) is more than sufficient to nourish vascular cells that are in close contact with the arterial blood and that exhibit only about 10% of the oxygen requirements of cardiac myocytes. Our own ultrastructural observations (25) showed that, although coronary microvascular endothelium reacts visibly to ischemia, it is actually more ischemia-resistant than myocytes and recovers faster after reperfusion. in experimental myocardial infarction, capillaries but not myocytes survive, a result that gives the false impression of increased capillary density. In short, it is likely that tissue ischemia is not sensed mainly by microvascular endothelium, but rather by cardiac myocytes. The sequence of events. Thus, the finding of a transcript in vascular wall shows the existence of a sequence of events: the ischemic myocyte signals to the microvascular environment that it should enter the cell cycle of mitosis. After that, endothelial and smooth muscle cells must communicate for the right balance of growth between these cells. The sequence of events may be as follows:
Progressive coronary stenosis leads to episodes of ischemia, depending on the degree of physical activity. Ischemic episodes lead to the expression of a hitherto not identified ischemia-related mitogen activator. After binding to a microvascular cell receptor, ischemiarelated mitogen activator initiates tibroblast growth factor transcription. Increased fibroblast growth factor transcription starts the cell cycle leading to mitosis in endothelial cells.
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Stimulated endothelial cells may produce platelet-derived growth factor that leads to smooth muscle cell mitosis. Finally, the differentiation factor TGF-P is produced to ensure specialized functions. Stimulated endothelium may also cause monocytes and platelets to adhere and unload and to produce additional growth factor or factors such as the angiogenetic peptide tumor necrosis factor.
The Ischemia-Related Mitogen-Activator Resists (So Far) Detection
If experimental conditions with progressive coronary occlusion are so timed that ischemia-related mitogen activator is present exclusively in the region at risk of infarction, the strategy of subtractive cloning is the most powerful approach for isolating an unknown peptide for which no structural information is available and that is probably extremely difficult to isolate because of its elusive nature. The peptide may also be rapidly destroyed locally and may not survive the unavoidably harsh isolation procedures.
Subtractive cloning. This method requires only the isolation of myocardial messenger RNA from the area of beginning collateralization and from a normal area of the same heart. The experimental area messenger RNA is reverse transcribed, and the resulting cDNA is hybridized with the messenger RNA from the control side: unique singlestranded cDNA coding for ischemia-related mitogen activator (its minus strand) does not find a complementary messenger RNA structure in the control side and remains single-stranded. After separation of single-stranded DNA from double-stranded DNA by hydroxyapatite, the plus strand is synthesized and the double-stranded cDNA is then cloned and sequenced. It is predictable that the two myocardial regions differ by more than one molecule or factor. The power of the method is that theoretically only one heart is needed and no previous information is required as to the nature of the unknown peptide.
Is Ischemia-Related Mitogen Activator
Only the Concerted Action of Lactate, pH, Adenosine and Nicotinamide-Adenine Dinucleotide?
Role of adenosine and nicotinic acid. Ischemia, the only condition known to stimulate collateral vessel growth, is usually viewed in terms of high energy phosphate breakdown and lactate production. Adenosine, a transient breakdown product of ATP, is a potent vasodilator; it is also a product of nicotinamide-adenine dinucleotide cleavage, as is nicotinic acid. Adenosine and nicotinic acid showed some indirect (nonmitogenic) angiogenic activity in some laboratories (26) . whereas a direct mitogenic activity of adenosine was found by others (27) in cultures of bovine microvascular coronary endothelium. Long-term infusion of adenosine into
